Skip to main content
NC

Nuvo Cares

Nuvo Group offers the INVU platform, an FDA-cleared remote pregnancy monitoring system that enables healthcare providers to conduct virtual non-stress tests and well-being checks for expectant mothers. This technology reduces patient travel and time spent on appointments, while improving access to clinical-grade fetal monitoring for high-need patients.

Miami, United StatesFounded 2007665K+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Traditional non-stress tests (NSTs) for fetal monitoring require in-person visits to a clinic, which can be burdensome for expectant mothers, especially those with high-risk pregnancies or limited access to transportation. This can lead to reduced adherence to recommended monitoring schedules and potential delays in identifying complications.

Solution

Nuvo Group offers the INVU platform, a remote pregnancy monitoring system that allows healthcare providers to conduct virtual NSTs and well-being checks for expectant mothers. The FDA-cleared platform includes a monitoring kit that is sent to the patient, who then downloads a mobile app and completes a self-guided training session. Clinicians can then schedule and conduct remote monitoring sessions, review and interpret the NST data, and integrate the session data into the EMR. INVU aims to expand access to care, boost staff efficiency, and increase patient satisfaction by reducing travel time and other barriers to care.

Target Audience

The primary target audience includes OBGYNs, maternal-fetal medicine specialists, OB nurses, and women's service line leaders, as well as pregnant individuals seeking convenient and accessible prenatal monitoring.

Features

  • Remote fetal non-stress tests (NSTs) conducted via a patient-worn monitoring kit and mobile app
  • Clinician web portal for scheduling remote monitoring sessions, reviewing NST data, and integrating with EMR systems
  • Self-guided patient training module within the mobile app
  • Clinically validated and FDA-cleared for remote use
  • Uterine contraction monitoring to enable remote, self-administered nonstress testing
This profile is AI-generated and may contain inaccuracies.